Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
- 2022 -
2023
-
2024
-
2025
August 2022 - 73 products
IP
CI
Budesonid Spirig HC 3 mg
20
PR
PR
k.A.
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Budesonid Spirig HC 3 mg
50
PR
PR
k.A.
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Budesonid Spirig HC 3 mg
100
PR
PR
k.A.
Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Baraclude 0.5 mg
30
335.33
382.30
10 %
Coated tablets: Entecavirum
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
L
IP
Baraclude 1 mg
30
465.74
521.85
10 %
Coated tablets: Entecavirum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A / SL / SO
FB
G
L
IP
CI
Sitagliptin Spirig HC 25 mg.
Filmtabletten
28
14.08
31.75
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Sitagliptin Spirig HC 50 mg.
Filmtabletten
28
14.08
31.75
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Sitagliptin Spirig HC 100 mg.
Filmtabletten
28
14.08
31.75
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Spirig HC 25 mg.
Filmtabletten
98
49.25
70.00
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Sitagliptin Spirig HC 50 mg.
Filmtabletten
98
49.25
70.00
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Sitagliptin Spirig HC 100 mg.
Filmtabletten
98
49.25
70.00
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Sitagliptin Spirig HC 25 mg.
Filmtabletten
100
50.26
71.05
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Sitagliptin Spirig HC 50 mg.
Filmtabletten
100
50.26
71.05
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Sitagliptin Spirig HC 100 mg.
Filmtabletten
100
50.26
71.05
10 %
Sitagliptini Hydrochloridum Monohydricum
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Olmesartan Amlodipin
Zentiva 20 mg/5 mg
28
16.74
34.65
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
CI
Olmesartan Amlodipin
Zentiva 20 mg/5 mg
98
47.81
68.45
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin
Zentiva 40 mg/5 mg
28
20.70
38.95
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin
Zentiva 40 mg/5 mg
98
59.58
81.25
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin
Zentiva 40 mg/10 mg
28
21.59
39.95
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
L
IP
Olmesartan Amlodipin
Zentiva 40 mg/10 mg
98
65.37
87.55
10 %
Coated tablets: 2 Active Agents
Helvepharm AG
B / SL / SG
FB
G
IP
Amikacin Ideogen 500 mg/2 ml
5
73.99
96.90
10 %
Konzentrat zur Herstellung einer Infusionslösung (i.v.) bzw. Injektionslösung (i.m.): Amikacinum 500mg / 2ml
Ideogen AG
A / SL / SG
FB
G
L
IP
V/S
Adacel 0.5 ml
0.5 ml
18.70
36.75
10 %
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
V/S
Adacel-Polio 0.5 ml
0.5 ml
24.00
42.50
10 %
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Azyter
6 x 0.25 g
6.52
16.30
10 %
Eye drops: Azithromycinum Dihydricum 3.75 mg
THEA Pharma S.A.
A / SL
FB
G
L
IP
Kapruvia 50 µg/ml
12 x 1 ml
314.87
358.85
10 %
Injection solution: Difelikefalinum 50 µg/ml
Vifor Fresenius
Medical Care Renal
Pharma Ltd.
B / SL
FB
G
L
IP
Saphnelo 300 mg/2 ml
895.73
990.60
10 %
Concentrate for infusion: Anifrolumabum 300mg / 2ml
AstraZeneca AG
A / SL
FB
G
L
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
6
7.65
17.55
10 %
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B / SL
FB
G
L
IP
CI
Jylamvo 2 mg/ml
109.73
135.75
10 %
Solution (oral): Methotrexatum 2 mg/ml
Ideogen AG
A / SL
FB
G
L
IP
CI
Sondelbay 20 mcg/80 mcl
239.81
278.40
10 %
Injektionslösung in einem Fertiginjektor: Teriparatidum Adnr 250 µg/ml
Accord Healthcare AG
B / SL
FB
G
IP
V/S
Adacel 0.5 ml
0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel 0.5 ml
10 x 0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel-Polio 0.5 ml
0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel-Polio 0.5 ml
0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel-Polio 0.5 ml
10 x 0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel-Polio 0.5 ml
10 x 0.5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
V/S
Adacel-Polio 0.5 ml
10 x 5 ml
PR
PR
k.A.
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
CI
Carvykti
30 x 70 ml
PR
PR
k.A.
Janssen-Cilag AG
A
FB
G
Macrogol Fairmed
20
PR
PR
k.A.
Strides Pharma
International AG
B
FB
G
Macrogol Fairmed
100
PR
PR
k.A.
Strides Pharma
International AG
B
FB
G
IP
Kapruvia 50 µg/ml
3 x 1 ml
PR
PR
k.A.
Injection solution: Difelikefalinum 50 µg/ml
Vifor Fresenius
Medical Care Renal
Pharma Ltd.
B
FB
G
Macrogol Fairmed Junior
30
PR
PR
k.A.
Soluble Powder: 4 Active Agents
Strides Pharma
International AG
B
FB
G
Macrogol Fairmed Junior
60
PR
PR
k.A.
Soluble Powder: 4 Active Agents
Strides Pharma
International AG
B
FB
G
IP
Lamzede 10 mg
PR
PR
k.A.
Dry substance: Velmanasum Alfa 10 mg
Chiesi SA
A
FB
G
IP
Lamzede 10 mg
5
PR
PR
k.A.
Dry substance: Velmanasum Alfa 10 mg
Chiesi SA
A
FB
G
IP
Lamzede 10 mg
10
PR
PR
k.A.
Dry substance: Velmanasum Alfa 10 mg
Chiesi SA
A
FB
G
IP
CI
Melatonin-Mepha 2 mg
21
PR
PR
k.A.
Delayed release tablets: Melatoninum 2 mg
Mepha Pharma AG
B
FB
G
IP
CI
Melatonin-Mepha 2 mg
100
PR
PR
k.A.
Delayed release tablets: Melatoninum 2 mg
Mepha Pharma AG
B
FB
G
IP
Baraclude 0.5 mg
30
PR
PR
k.A.
Coated tablets: Entecavirum
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Baraclude 0.5 mg
30
PR
PR
k.A.
Coated tablets: Entecavirum
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Baraclude 1 mg
30
PR
PR
k.A.
Coated tablets: Entecavirum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
Baraclude 1 mg
30
PR
PR
k.A.
Coated tablets: Entecavirum 1 mg
APS-Arzneimittel-
Parallelimport-
Service AG
A
FB
G
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
4
PR
PR
k.A.
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
8
PR
PR
k.A.
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IP
CI
D3 VitaCaps 24,000 IU
(600 μg)
12
PR
PR
k.A.
Soft capsules: Cholecalciferolum 600 µg
Pierre Fabre Pharma SA
B
FB
G
IP
Amikacin Ideogen 500 mg/2 ml
PR
PR
k.A.
Konzentrat zur Herstellung einer Infusionslösung (i.v.) bzw. Injektionslösung (i.m.): Amikacinum 500mg / 2ml
Ideogen AG
A
FB
G
IP
Amikacin Ideogen 1 g/4 ml
PR
PR
k.A.
Konzentrat zur Herstellung einer Infusionslösung (i.v.) bzw. Injektionslösung (i.m.): Amikacinum
Ideogen AG
A
FB
G
IP
Amikacin Ideogen 1 g/4 ml
5
PR
PR
k.A.
Konzentrat zur Herstellung einer Infusionslösung (i.v.) bzw. Injektionslösung (i.m.): Amikacinum
Ideogen AG
A
FB
G
Omeprazol Xiromed 10 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 10 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 10 mg
28
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 10 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 10 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 10 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 10 mg
98
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 10 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 20 mg
7
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 20 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 20 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 20 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 20 mg
28
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 20 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 20 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 20 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 20 mg
98
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 20 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 40 mg
7
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 40 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 40 mg
14
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 40 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 40 mg
28
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 40 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 40 mg
56
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 40 mg
Xiromed SA
B
FB
G
Omeprazol Xiromed 40 mg
98
PR
PR
k.A.
magensaftresistente Hartkapseln: Omeprazolum 40 mg
Xiromed SA
B
FB
G
IP
CI
Ganirelix Labatec 0,25 mg
PR
PR
k.A.
solution injectable en seringue préremplie: Ganirelixum
Labatec Pharma SA
A
FB
G
IP
CI
Ganirelix Labatec 0,25 mg
5
PR
PR
k.A.
solution injectable en seringue préremplie: Ganirelixum
Labatec Pharma SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home